Iron Metabolism as a Therapeutic Vulnerability in Stem Cell-Like Castration-Resistant Prostate Cancer
Wanli Cheng, Andrea Brunello, Francesco Bonollo, Thomas M. Marti, Panagiotis Chouvardas, David P. Labbé, Marta De Menna, George Niklaus Thalmann, Sofia Karkampouna, Marianna Kruithof‐de Julio
This study identifies iron metabolism as a therapeutic target in stem cell-like castration-resistant prostate cancer by showing that inhibiting NRF2 induces ferroptosis in CD44hi cells.
bioRxiv · Feb 25, 2026 · PreprintCancer Biology